SEIBULE Side Effects

7012934-2 | Hepatic Function Abnormal
on Sep 13, 2010 Male patient from JAPAN , 65 years of age, was treated with Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Seibule dosage: Total Daily Dose Of 50 Mg.

7007677-5 | Pneumatosis Intestinalis
Patient was taking Seibule (View Usage). Patient had the following side effects: pneumatosis intestinalis on Sep 10, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, was diagnosed with diabetes mellitus, hyperuricaemia, hypertension, hepatic cirrhosis, gastroenteritis (What is gastroenteritis?), chronic hepatitis, gastritis, neuropathy peripheral and. Seibule dosage: 50 Mg, Unk. During the same period patient was treated with SALOBEL (100 Mg, Unk) (View Salobel Review and Salobel Label ), NU LOTAN (25 Mg, Unk) (View Nu Lotan Review and Nu Lotan Label ), PORTOLAC (6 G, Unk) (View Portolac Review and Portolac Label ), BIOFERMIN (3 G, Unk) (View Biofermin Review and Biofermin Label ), URSO 250 (300 Mg, Unk) (View Urso 250 Review and Urso 250 Label ), TAGAMET (600 Mg, Unk) (View Tagamet Review and Tagamet Label ), LIVACT (8.3 G, Unk) (View Livact Review and Livact Label ), METHYCOBAL (1500 Ug, Unk) (View Methycobal Review and Methycobal Label ).

7007393-X | Abdominal Pain Upper, Cholecystitis, Pneumatosis Intestinalis, Renal Cyst
Adverse event was reported on Sep 08, 2010 by a Female patient taking Seibule (View Usage) (Dosage: 100 Mg, Unk) was diagnosed with type 2 diabetes mellitus, diabetic neuropathy, osteoarthritis (What is osteoarthritis?), dysuria, hyperlipidaemia and. Location: JAPAN , 75 years of age, After Seibule was administered, patient had the following side effects: abdominal pain upper, cholecystitis, pneumatosis intestinalis, renal cyst. During the same period patient was treated with LANTUS (14 Iu, Unk) (View Lantus Review and Lantus Label ), KINEDAK (150 Mg, Unk) (View Kinedak Review and Kinedak Label ), SELBEX (100 Mg, Unk) (View Selbex Review and Selbex Label ), CELECOXIB (200 Mg, Unk) (View Celecoxib Review and Celecoxib Label ), VESICARE (5 Mg, Unk) (View Vesicare Review and Vesicare Label ), LIPIDIL (100 Mg, Unk) (View Lipidil Review and Lipidil Label ), PARIET (10 Mg, Unk) (View Pariet Review and Pariet Label ). Patient was hospitalized.

6977157-1 | Pneumatosis Intestinalis
on Aug 30, 2010 Female patient from JAPAN , 75 years of age, was treated with Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: pneumatosis intestinalis. Seibule dosage: . Patient was hospitalized.


6971610-2 | Hepatic Function Abnormal
on Jun 23, 2010 Male patient from JAPAN , 65 years of age, was treated with Seibule (View Usage). Patient had the following side effects: hepatic function abnormal. Seibule dosage: Total Daily Dose Of 50 Mg.

6971501-7 | Hepatic Function Abnormal, Pneumatosis Intestinalis
Patient was taking Seibule (View Usage). After Seibule was administered, patient had the following side effects: hepatic function abnormal, pneumatosis intestinalis on Jun 09, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, . Seibule dosage: 150 Mg Per Day.

6959294-0 | Abdominal Pain Lower, Melaena, Pneumatosis Intestinalis, Rectal Haemorrhage
Adverse event was reported on Aug 10, 2010 by a Male patient taking Seibule (View Usage) (Dosage: Unk) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 58 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain lower, melaena, pneumatosis intestinalis, rectal haemorrhage. During the same period patient was treated with GLYBURIDE (1.25 Mg, Unk) (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

6941464-9 | Abdominal Pain Lower, Melaena, Pneumatosis Intestinalis, Rectal Haemorrhage
on Aug 10, 2010 Male patient from JAPAN , 58 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Seibule (View Usage). Patient had the following side effects: abdominal pain lower, melaena, pneumatosis intestinalis, rectal haemorrhage. Seibule dosage: Unk. During the same period patient was treated with GLYBURIDE (1.25 Mg, Unk) (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

6934081-8 | Diarrhoea, Eye Swelling, Swelling Face
on Aug 07, 2010 Female patient from JAPAN , 55 years of age, was diagnosed with diabetes mellitus and was treated with Seibule (View Usage). After Seibule was administered, patient had the following side effects: diarrhoea, eye swelling, swelling face. Seibule dosage: Unk. During the same period patient was treated with AMARYL (Unk) (View Amaryl Review and Amaryl Label ).

6923463-6 | Hepatic Function Abnormal
Patient was taking Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal on Aug 03, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with type 2 diabetes mellitus, onychomycosis and. Seibule dosage: 25 Mg, 3x/day. During the same period patient was treated with LAMISIL (Unk) (View Lamisil Review and Lamisil Label ), CRESTOR (View Crestor Review and Crestor Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), NORVASC (View Norvasc Review and Norvasc Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMARYL (Unk) (View Amaryl Review and Amaryl Label ), MELBIN (500 Mg, Unk) (View Melbin Review and Melbin Label ). Patient was hospitalized.

6923112-7 | Diarrhoea, Swelling Face
Adverse event was reported on Jul 30, 2010 by a Female patient taking Seibule (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus and. Location: JAPAN , 55 years of age, Patient had the following side effects: diarrhoea, swelling face. During the same period patient was treated with AMARYL (Unk) (View Amaryl Review and Amaryl Label ).

6826670-6 | Hypoglycaemia
on Jun 29, 2010 Female patient from JAPAN , 76 years of age, was treated with Seibule (View Usage). After Seibule was administered, patient had the following side effects: hypoglycaemia. Seibule dosage: Unk.

6819391-7 | Hypoglycaemia
on Jun 24, 2010 Male patient from JAPAN , 68 years of age, was treated with Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Seibule dosage: 50 Mg, Daily.

6813129-5 | Hypoglycaemia
Patient was taking Seibule (View Usage). Patient had the following side effects: hypoglycaemia on Jun 24, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, . Seibule dosage: 50 Mg Daily.

6810600-7 | Hypoglycaemia
Adverse event was reported on Jun 25, 2010 by a Female patient taking Seibule (View Usage) (Dosage: Unk Mg, Unk) . Location: JAPAN , 76 years of age, After Seibule was administered, patient had the following side effects: hypoglycaemia.

6810227-7 | Hepatic Function Abnormal
on Mar 25, 2010 Female patient from JAPAN , 78 years of age, was treated with Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Seibule dosage: Unk.

6810220-4 | Hepatic Function Abnormal
on Jun 07, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with diabetes mellitus and was treated with Seibule (View Usage). Patient had the following side effects: hepatic function abnormal. Seibule dosage: 112.5 Mg, Unk.

6779894-0 | Hepatic Function Abnormal
Patient was taking Seibule (View Usage). After Seibule was administered, patient had the following side effects: hepatic function abnormal on Jun 07, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, was diagnosed with diabetes mellitus and. Seibule dosage: 112.5 Mg, Unk.

6762560-5 | Blood Creatine Phosphokinase Increased, Dehydration, Diarrhoea, Hyperglycaemia, Renal Impairment
Adverse event was reported on May 27, 2010 by a Male patient taking Seibule (View Usage) (Dosage: 150 Mg, Unk) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 27 years of age, Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, dehydration, diarrhoea, hyperglycaemia, renal impairment. During the same period patient was treated with OLMETEC (30 Mg, 1x/day) (View Olmetec Review and Olmetec Label ), NATRIX (1 Mg, Unk) (View Natrix Review and Natrix Label ), ALLOPURINOL (50 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), SODIUM BICARBONATE (3 G, Unk) (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), NU LOTAN (25 Mg, Unk) (View Nu Lotan Review and Nu Lotan Label ), KREMEZIN (6 G, Unk) (View Kremezin Review and Kremezin Label ), HUMALOG MIX (34 Iu, Unk) (View Humalog Mix Review and Humalog Mix Label ). Patient was hospitalized.

6753806-8 | Blood Creatine Phosphokinase Increased, Dehydration, Diarrhoea, Hyperglycaemia, Renal Impairment
on May 19, 2010 Male patient from JAPAN , 27 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Seibule (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, dehydration, diarrhoea, hyperglycaemia, renal impairment. Seibule dosage: 150 Mg, Unk. During the same period patient was treated with OLMESARTAN MEDOXOMIL (30 Mg, Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), NATRIX (1 Mg, Unk) (View Natrix Review and Natrix Label ), ALLOPURINOL (50 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), SODIUM BICARBONATE (3 G, Unk) (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), NU LOTAN (25 Mg, Unk) (View Nu Lotan Review and Nu Lotan Label ), KREMEZIN (6 G, Unk) (View Kremezin Review and Kremezin Label ), HUMALOG MIX (34 Iu, Unk) (View Humalog Mix Review and Humalog Mix Label ). Patient was hospitalized.

6740057-6 | Hepatic Function Abnormal
on May 13, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with diabetes mellitus, hypertension, renal failure chronic, anaemia, cerebral infarction, gastritis and was treated with Seibule (View Usage). After Seibule was administered, patient had the following side effects: hepatic function abnormal. Seibule dosage: 150 Mg, Unk. During the same period patient was treated with OLMESARTAN MEDOXOMIL (20 Mg, Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), NORVASC (10 Mg, Unk) (View Norvasc Review and Norvasc Label ), LASIX (40 Mg, Unk) (View Lasix Review and Lasix Label ), FERRO GRADUMET (105 Mg, Unk) (View Ferro-gradumet Review and Ferro-gradumet Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), LAFUTIDINE (10 Mg, Unk) (View Lafutidine Review and Lafutidine Label ). Patient was hospitalized.

6732833-0 | Liver Disorder
Patient was taking Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on May 04, 2010 from JAPAN Additional patient health information: Male patient , 63 years of age, . Seibule dosage: 150 Mg, Unk.

6732832-9 | Liver Disorder
Adverse event was reported on May 04, 2010 by a Female patient taking Seibule (View Usage) (Dosage: 75 Mg, Unk) . Location: JAPAN , 59 years of age, Patient had the following side effects: liver disorder.

6732831-7 | Hepatic Function Abnormal
on May 04, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with diabetes mellitus and was treated with Seibule (View Usage). After Seibule was administered, patient had the following side effects: hepatic function abnormal. Seibule dosage: Unk.

6728566-7 | Liver Disorder
on May 04, 2010 Male patient from JAPAN , 81 years of age, was treated with Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Seibule dosage: 75 Mg/day.

6728548-5 | Liver Disorder
Patient was taking Seibule (View Usage). Patient had the following side effects: liver disorder on May 04, 2010 from JAPAN Additional patient health information: Male patient , 58 years of age, . Seibule dosage: Unk.

6728541-2 | Liver Disorder
Adverse event was reported on May 04, 2010 by a Female patient taking Seibule (View Usage) (Dosage: 150 Mg/day) . Location: JAPAN , 64 years of age, After Seibule was administered, patient had the following side effects: liver disorder.

6728415-7 | Liver Disorder
on May 04, 2010 Male patient from JAPAN , 82 years of age, was treated with Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Seibule dosage: 75 Mg/day.

6728412-1 | Liver Disorder
on May 04, 2010 Male patient from JAPAN , 76 years of age, was treated with Seibule (View Usage). Patient had the following side effects: liver disorder. Seibule dosage: Unk.

6728410-8 | Liver Disorder
Patient was taking Seibule (View Usage). After Seibule was administered, patient had the following side effects: liver disorder on May 04, 2010 from JAPAN Additional patient health information: Female patient , 60 years of age, . Seibule dosage: Unk.

6728409-1 | Liver Disorder
Adverse event was reported on May 04, 2010 by a Male patient taking Seibule (View Usage) (Dosage: 150 Mg, Unk) . Location: JAPAN , 60 years of age, Patient experienced the following unwanted or unexpected effects: liver disorder.

6728407-8 | Blood Pressure Increased
on May 02, 2010 Male patient from JAPAN , 70 years of age, was treated with Seibule (View Usage). Patient had the following side effects: blood pressure increased. Seibule dosage: Unk.

6728317-6 | Liver Disorder
on May 04, 2010 Male patient from JAPAN , 54 years of age, was treated with Seibule (View Usage). After Seibule was administered, patient had the following side effects: liver disorder. Seibule dosage: 150 Mg, Unk.

6726156-3 | Hyperkalaemia, Liver Disorder
Patient was taking Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, liver disorder on May 04, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, . Seibule dosage: 150 Mg, Unk.

6726151-4 | Ventricular Extrasystoles
Adverse event was reported on May 04, 2010 by a Female patient taking Seibule (View Usage) (Dosage: 100 Mg, Unk) . Location: JAPAN , 82 years of age, Patient had the following side effects: ventricular extrasystoles.

6725890-9 | Liver Disorder
on May 04, 2010 Female patient from JAPAN , 70 years of age, was treated with Seibule (View Usage). After Seibule was administered, patient had the following side effects: liver disorder. Seibule dosage: Unk Mg, Unk.

6720341-2 | Hypoglycaemia
on Apr 29, 2010 Male patient from JAPAN , 57 years of age, was treated with Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Seibule dosage: 50 Mg, Unk.

6707138-4 | Ileus
Patient was taking Seibule (View Usage). Patient had the following side effects: ileus on Apr 22, 2010 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with diabetes mellitus and. Seibule dosage: 50 Mg, 3x/day. During the same period patient was treated with STARSIS (270 Mg, Unk) (View Starsis Review and Starsis Label ), AMLODIN (5 Mg, Unk) (View Amlodin Review and Amlodin Label ), OLMESARTAN MEDOXOMIL (20 Mg, Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6702823-2 | Liver Disorder
Adverse event was reported on Apr 15, 2010 by a Male patient taking Seibule (View Usage) (Dosage: Unk) . Location: JAPAN , 54 years of age, After Seibule was administered, patient had the following side effects: liver disorder.

6702644-0 | Abdominal Pain Lower, Melaena, Pneumatosis Intestinalis
on Apr 14, 2010 Male patient from JAPAN , 58 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain lower, melaena, pneumatosis intestinalis. Seibule dosage: 150 Mg, Unk. During the same period patient was treated with GLYBURIDE (1.25 Mg, Unk) (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

6701626-2 | Blood Creatine Phosphokinase Increased, Dehydration, Diarrhoea, Hyperglycaemia, Renal Impairment
on Apr 15, 2010 Male patient from JAPAN , 27 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Seibule (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, dehydration, diarrhoea, hyperglycaemia, renal impairment. Seibule dosage: Unk. During the same period patient was treated with ALLOPURINOL (50 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), SODIUM BICARBONATE (3 G, Unk) (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), NU LOTAN (25 Mg, Unk) (View Nu Lotan Review and Nu Lotan Label ), KREMEZIN (6 G, Unk) (View Kremezin Review and Kremezin Label ), HUMALOG MIX (34 Iu, Unk) (View Humalog Mix Review and Humalog Mix Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized.

6699011-5 | Liver Disorder
Patient was taking Seibule (View Usage). After Seibule was administered, patient had the following side effects: liver disorder on Apr 16, 2010 from JAPAN Additional patient health information: Male patient , 78 years of age, was diagnosed with diabetes mellitus and. Seibule dosage: 50 Mg, 3x/day. During the same period patient was treated with AMARYL (2 Mg, Unk) (View Amaryl Review and Amaryl Label ), ENALAPRIL MALEATE (5 Mg, Unk) (View Enalapril Maleate Review and Enalapril Maleate Label ), CHLORMADINONE ACETATE (50 Mg, Unk) (View Chlormadinone Acetate Review and Chlormadinone Acetate Label ), GASLON (4 Mg, Unk) (View Gaslon Review and Gaslon Label ), UBRETID (10 Mg, Unk) (View Ubretid Review and Ubretid Label ), URIEF (8 Mg, Unk) (View Urief Review and Urief Label ). Patient was hospitalized.

6698613-X | Abdominal Pain Lower, Melaena, Pneumatosis Intestinalis
Adverse event was reported on Apr 14, 2010 by a Male patient taking Seibule (View Usage) (Dosage: 150 Mg, Unk) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 58 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain lower, melaena, pneumatosis intestinalis. During the same period patient was treated with GLYBURIDE (1.25 Mg, Unk) (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

6681723-0 | Liver Disorder
on Apr 05, 2010 Male patient from JAPAN , 54 years of age, was treated with Seibule (View Usage). Patient had the following side effects: liver disorder. Seibule dosage: Unk.

6678799-3 | Pneumatosis Intestinalis
on Apr 01, 2010 Male patient from JAPAN , 58 years of age, was diagnosed with diabetes mellitus and was treated with Seibule (View Usage). After Seibule was administered, patient had the following side effects: pneumatosis intestinalis. Seibule dosage: . Patient was hospitalized.

6675147-X | Hepatic Function Abnormal
Patient was taking Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal on Mar 30, 2010 from JAPAN Additional patient health information: Female patient , 56 years of age, was diagnosed with diabetes mellitus and. Seibule dosage: 75 Mg Daily. During the same period patient was treated with FLOMOX (300 Mg, Unk) (View Flomox Review and Flomox Label ), LORCAM (2 Mg, Unk) (View Lorcam Review and Lorcam Label ), MEVALOTIN (10 Mg, Unk) (View Mevalotin Review and Mevalotin Label ), ACTOS (15 Mg, Unk) (View Actos Review and Actos Label ), LANTUS (8 Iu, Unk) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6675144-4 | Fatigue, Liver Disorder, Thirst
Adverse event was reported on Mar 29, 2010 by a Male patient taking Seibule (View Usage) (Dosage: 150 Mg, Unk) was diagnosed with diabetes mellitus, type 2 diabetes mellitus, nephrotic syndrome, gastroenteritis (What is gastroenteritis?) and. Location: JAPAN , 71 years of age, Patient had the following side effects: fatigue, liver disorder, thirst. During the same period patient was treated with PREDONINE (Unk) (View Predonine Review and Predonine Label ), PARIET (10 Mg, Unk) (View Pariet Review and Pariet Label ), ZETIA (10 Mg, Unk) (View Zetia Review and Zetia Label ), ALFAROL (Unk) (View Alfarol Review and Alfarol Label ), LIPITOR (5 Mg, Unk) (View Lipitor Review and Lipitor Label ), MICARDIS (40 Mg, Unk) (View Micardis Review and Micardis Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ).

6669647-6 | Ileus
on Mar 25, 2010 Female patient from JAPAN , 72 years of age, was diagnosed with diabetes mellitus and was treated with Seibule (View Usage). After Seibule was administered, patient had the following side effects: ileus. Seibule dosage: 50 Mg, 3x/day. During the same period patient was treated with STARSIS (270 Mg, Unk) (View Starsis Review and Starsis Label ), AMLODIPINE (5 Mg, Unk) (View Amlodipine Review and Amlodipine Label ), OLMESARTAN MEDOXOMIL (20 Mg, Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6665858-4 | Hepatic Function Abnormal
on Mar 23, 2010 Female patient from JAPAN , 56 years of age, was diagnosed with diabetes mellitus and was treated with Seibule (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Seibule dosage: 75 Mg Daily. During the same period patient was treated with FLOMOX (300 Mg, Unk) (View Flomox Review and Flomox Label ), LORCAM (2 Mg, Unk) (View Lorcam Review and Lorcam Label ), MEVALOTIN (10 Mg, Unk) (View Mevalotin Review and Mevalotin Label ), ACTOS (15 Mg, Unk) (View Actos Review and Actos Label ), LANTUS (8 Iu, Unk) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6654493-X | Hyperkalaemia
Patient was taking Seibule (View Usage). Patient had the following side effects: hyperkalaemia on Mar 17, 2010 from JAPAN Additional patient health information: Male patient , 76 years of age, was diagnosed with hypertension and. Seibule dosage: Unk. During the same period patient was treated with MICARDIS (Unk) (View Micardis Review and Micardis Label ), MITIGLINIDE (Unk) (View Mitiglinide Review and Mitiglinide Label ), LANSOPRAZOLE (15 Mg, Unk) (View Lansoprazole Review and Lansoprazole Label ), NAUZELIN (30 Mg, Unk) (View Nauzelin Review and Nauzelin Label ).